Radiochemistry and Pre-clinical First Steps
Radiochemistry is integral to tracer development, not only to enable labelling of putative tracers for early pre-clinical evaluation, but also to bridge efforts in medicinal chemistry, biological evaluation, tracer selection, method development, and tracer production for early human studies. INM has historically relied on access to experimental radiotracers through national and international collaborations, and it has been a long-term strategic goal for the Institute to establish its own radiochemistry group in order to stay at the forefront of nuclear imaging.
KeywordsDrug Efflux Pump Tracer Development Tracer Production Experimental Radiotracer Tracer Selection
Unable to display preview. Download preview PDF.
- Årstad E., Gitto R., Chimirri A., Caruso R., Constanti A., Turton D., Hume S.P., Ahmad R., Pilowsky L.S., Luthra S.K (2006). Closing in on the AMPA receptor: Synthesis and evaluation of 2-acyl-1-(p-chlorophenyl)-6-methoxy-7-[11C]methoxy-1,2,3,4-tetrahydroisoquinoline as a potential PET tracer, Bioorganic & Medicinal Chemistry, 14 (14), 4712–4717.CrossRefGoogle Scholar
- Schoultz BW, Hjornevik T, Willoch F, Marton J, Noda A, Murakami Y, Miyoshi S, Nishimura S, Årstad E, Drzezga A, Matsunari I, Henriksen G (2010). Evaluation of the kappa-opioid receptor-selective tracer [(11)C]GR103545 in awake rhesus macaques. Eur J Nucl Med Mol Imaging. 37(6):1174–1180.PubMedCrossRefGoogle Scholar